Conexeu Sciences Inc. CNXU
—
3.89
(0.07)
(1.77%)
as of 25 Sep
- Market cap
- $111.7M
- P/E
- 0.0×
Follow CNXU
Insider Buys
alert about insiders buying in the last 12 month
| Older periods | Oct '25 | Jan '26 | Apr '26 | Jul '26 | |
|---|---|---|---|---|---|
Current Ratio |
+4 more quarters Free account |
22.20 | 18.51 | 14.93 | 5.31 |
Net Debt/EBITDA |
2.59 | 3.91 | 3.08 | 0.29 | |
Debt/Assets |
0.00% | 0.00% | 0.00% | 0.00% | |
Debt/Equity |
0.00 | 0.00 | 0.00 | 0.00 | |
Asset Turnover |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF/Net income |
0.23 | 0.89 | 0.78 | 0.87 | |
Capex/Depreciation |
0.00 | (0.73) | (2.62) | (7.67) | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Intangible Assets out of Total Assets |
0.02 | 0.02 | 0.02 | 0.02 | |
Free Cash Flow per Share |
(0.03) | (0.08) | (0.09) | (0.25) | |
Cash per Share |
0.38 | 0.33 | 0.36 | 0.08 | |
Shareholders Equity per Share |
0.58 | 0.34 | 0.35 | 0.22 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
0.58 | 0.34 | 0.35 | 0.22 | |
Free Cash Flow |
(0.43) | (1.54) | (1.83) | (6.80) | |
Working Capital |
7.12 | 7.06 | 7.38 | 5.48 | |
Capital Expenditures |
0.00 | 0.00 | (0.03) | (0.04) | |
Net Current Asset Value |
7.12 | 6.58 | 6.91 | 5.45 | |
| Other line items | |||||
Quick Ratio |
20.35 | 16.65 | 13.78 | 1.74 | |
Revenue per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF per Share |
(0.03) | (0.08) | (0.09) | (0.25) | |
Capex per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Average Payables |
— | — | — | 0.58 | |
Average Assets |
4.11 | 3.85 | 4.10 | 3.58 | |
Average Common Equity |
— | — | — | 2.97 | |
Capex to Sales |
0.00 | 0.00 | 0.00 | 0.00 | |
Net Profit Margin |
0.00% | 0.00% | 0.00% | 0.00% |
Columns are period end dates